Area of research
Virology · Infectious Diseases
Research interest
Research interests include HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, and vaccines and immunoinformatics approaches.
Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning
Dynamics and durability of HIV-1 neutralization are determined by viral replication
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination
Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection
Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays v2
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
dms-view: Interactive visualization tool for deep mutational scanning data
APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1
Pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays v1
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide
HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans